SASTASUNDR

Sastasundar Ventures Share Price

₹293.00 +2.15 (0.74%)

21 Nov, 2024 14:29

SIP TrendupStart SIP in SASTASUNDR

Start SIP

Performance

  • Low
  • ₹284
  • High
  • ₹294
  • 52 Week Low
  • ₹276
  • 52 Week High
  • ₹507
  • Open Price₹291
  • Previous Close₹291
  • Volume52,282

Investment Returns

  • Over 1 Month -5.34%
  • Over 3 Month -6.32%
  • Over 6 Month -2.42%
  • Over 1 Year -25.55%
SIP Lightning

Smart Investing Starts Here Start SIP with Sastasundar Ventures for Steady Growth!

Invest Now

Sastasundar Ventures Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -1128.1
  • PEG Ratio
  • 2.9
  • Market Cap Cr
  • 932
  • P/B Ratio
  • 3.4
  • Average True Range
  • 16.62
  • EPS
  • 39.58
  • Dividend Yield
  • 0
  • MACD Signal
  • 4.55
  • RSI
  • 37.66
  • MFI
  • 63.95

Sastasundar Ventures Financials

Sastasundar Ventures Technicals

EMA & SMA

Current Price
₹293.00
+ 2.15 (0.74%)
pointer
  • stock-down_img
  • Bullish Moving Average 0
  • stock-up_img
  • Bearish Moving Average 16
  • 20 Day
  • ₹313.97
  • 50 Day
  • ₹311.98
  • 100 Day
  • ₹314.80
  • 200 Day
  • ₹321.19

Resistance and Support

295.98 Pivot Speed
  • R3 324.77
  • R2 316.88
  • R1 303.87
  • S1 282.97
  • S2 275.08
  • S3 262.07

What's your outlook on Sastasundar Ventures?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Sastasundar Ventures Ltd. operates an online healthcare and pharmacy platform, providing affordable medicines, health products, and diagnostic services. It focuses on delivering high-quality healthcare solutions across India through a digital marketplace and integrated supply chain.

Sastasundar Ventures has an operating revenue of Rs. 951.57 Cr. on a trailing 12-month basis. An annual revenue growth of 35% is outstanding, Pre-tax margin of 4% needs improvement, ROE of 1% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 74 which is a FAIR score but needs to improve its earnings, a RS Rating of 17 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D which indicates heavy supply, Group Rank of 34 indicates it belongs to a strong industry group of Internet-Content and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Sastasundar Ventures Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-14 Quarterly Results
2024-07-29 Quarterly Results
2024-05-30 Audited Results
2024-01-31 Quarterly Results
2023-11-10 Quarterly Results

Sastasundar Ventures F&O

Sastasundar Ventures Shareholding Pattern

73.92%
0%
0.99%
14.47%
10.62%

About Sastasundar Ventures

  • NSE Symbol
  • SASTASUNDR
  • BSE Symbol
  • 533259
  • Chairman & Managing Director
  • Mr. Banwari Lal Mittal
  • ISIN
  • INE019J01013

Similar Stocks to Sastasundar Ventures

Sastasundar Ventures FAQs

Sastasundar Ventures share price is ₹293 As on 21 November, 2024 | 14:15

The Market Cap of Sastasundar Ventures is ₹932 Cr As on 21 November, 2024 | 14:15

The P/E ratio of Sastasundar Ventures is -1128.1 As on 21 November, 2024 | 14:15

The PB ratio of Sastasundar Ventures is 3.4 As on 21 November, 2024 | 14:15

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
 
footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23